Trial Profile
A Phase 1 Randomized, Double-masked, Vehicle-controlled, Dose Escalation Study of the Ocular Safety and Tolerability of MC-1101 in Medically Stable Individuals
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2014
Price :
$35
*
At a glance
- Drugs MC 1101 (Primary)
- Indications Dry age-related macular degeneration
- Focus Adverse reactions
- Sponsors MacuCLEAR
- 24 Apr 2014 New trial record